Clinical outcomes of baricitinib in patients with systemic lupus erythematosus: Pooled analysis of SLE-BRAVE-I and SLE-BRAVE-II trials

• Juntao Yin ,

  Contributed equally to this work with: Juntao Yin, Yantao Hou, Chaoyang Wang, Changjiang Qin

  Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Software, Visualization, Writing – original draft

  Affiliation Department of Pharmacy, Huaihe Hospital, Henan University, Kaifeng, China

  ⨯
• Yantao Hou ,

  Contributed equally to this work with: Juntao Yin, Yantao Hou, Chaoyang Wang, Changjiang Qin

  Roles Data curation, Formal analysis, Software, Writing – original draft

  Affiliation College of New Energy and Intelligent Vehicles, Henan Technical Institute, Zhengzhou, China

  ⨯
• Chaoyang Wang ,

  Contributed equally to this work with: Juntao Yin, Yantao Hou, Chaoyang Wang, Changjiang Qin

  Roles Conceptualization, Methodology, Software, Visualization, Writing – original draft

  * E-mail: qincjyz@outlook.com (CQ); wangcy202402@126.com (CW)

  Affiliation Department of General Surgery, Huaihe Hospital, Henan University, Kaifeng, China

  ⨯
• Changjiang Qin

  Contributed equally to this work with: Juntao Yin, Yantao Hou, Chaoyang Wang, Changjiang Qin

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Supervision, Writing – review & editing

  * E-mail: qincjyz@outlook.com (CQ); wangcy202402@126.com (CW)

  Affiliation Department of General Surgery, Huaihe Hospital, Henan University, Kaifeng, China

  https://orcid.org/0009-0004-3472-4784

  ⨯